CX3CL1 and neoplasm: Contrary to our results, a previous study suggested that CX3CR1 (lack of the allele I249) might play a limited or insignificant role in CRC, and plasma FKN/CX3CL1 does not appear to be a valuable tumor marker in CRC (77).